About RiboBio
RiboBio is a company based in Guangzhou (China) founded in 2004.. RiboBio has raised $40 million across 1 funding round from investors including SANY Group and Panlin Capital. RiboBio operates in a competitive market with competitors including ArcherDX, GenScript, Sino Biological, Miltenyi Biotec and Sebia, among others.
- Headquarter Guangzhou, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 1 rounds
-
Latest Funding Round
$40 M (USD), Series E
Jul 29, 2022
-
Investors
SANY Group
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RiboBio
RiboBio has successfully raised a total of $40M through 1 strategic funding round. The most recent funding activity was a Series E round of $40 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series E — $40.0M
-
First Round
First Round
(29 Jul 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series E - RiboBio | Valuation | Panlin Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RiboBio
RiboBio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include SANY Group and Panlin Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Manufacturer of construction & mining equipment, port, and oil drilling machinery
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RiboBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RiboBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ribobio Comparisons
Competitors of RiboBio
RiboBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, GenScript, Sino Biological, Miltenyi Biotec and Sebia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Electrophoresis-based in vitro diagnostics products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about RiboBio
When was RiboBio founded?
RiboBio was founded in 2004 and raised its 1st funding round 18 years after it was founded.
Where is RiboBio located?
RiboBio is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.
Is RiboBio a funded company?
RiboBio is a funded company, having raised a total of $40M across 1 funding round to date. The company's 1st funding round was a Series E of $40M, raised on Jul 29, 2022.
What does RiboBio do?
Founded in 2004 and based in Guangzhou, China, oligonucleotides are developed by RiboBio within the biotechnology sector. A GMP-approved manufacturing facility is operated for production, alongside process development services. RD offerings encompass RNAimiRNA functional studies, high-throughput screens for RNAi and small molecules, and microarray analysis for mRNA and miRNA. A proprietary solid-phase synthesis process for RNA oligonucleotides has been established.
Who are the top competitors of RiboBio?
RiboBio's top competitors include Sino Biological, ArcherDX and GenScript.
Who are RiboBio's investors?
RiboBio has 2 investors. Key investors include SANY Group, and Panlin Capital.